Despite several trials of delivering medical supplies being...
Category:
Health
Latest
What is Marburg disease and should India be worried?
According to the WHO, the Marburg virus disease is a highly...
Patient safety is an imperative dimension in ensuring quality healthcare: MoS Bharati Pawar
Bharati Pravin Pawar,Minister of State for Health and Family...
AstraZeneca gets partial immunity in low-cost EU vaccine deal
Drugmakers have called on EU regulators to set up a Europe-wide compensation scheme, while patients’ organizations are calling for an EU-wide fund financed by pharmaceutical firms that would compensate for unexpected side-effects.
The EU legal regime is among the least favorable to drugmakers on compensation claims, although plaintiffs have rarely managed to win as the law requires them to prove the link between an illness and a vaccine that may have caused it.
The United States has granted immunity from liability for COVID-19 vaccines that receive regulatory approval. Meanwhile, Russia has said it would shoulder some of the legal liability should anything go wrong with the vaccine developed by Moscow’s Gamaleya Institute.
World Bank seeks board approval for $12 billion coronavirus vaccine financing plan
Malpass said the World Bank plan aimed to put poor and middle-income countries, where the virus is spreading most rapidly, on the same footing as richer countries by ensuring they have financing to secure supplies and a system for distribution, which will encourage drugmakers to meet their demand.
Without early doses that can bring outbreaks under control, many of these countries risk economic collapse that will push hundreds of millions of people back into poverty.
India’s coronavirus infections surge to 6.23 million
BENGALURU India’s coronavirus case tally surged to 6.23 million after it reported 80,472 new infections in the last 24 hours, data from the health ministry showed on Wednesday. Deaths from coronavirus infections rose by 1,179 in the last 24 hours to...
‘Take home’ lawsuits over COVID infections could be costly for U.S. employers
Between 7% and 9% of the roughly 200,000 U.S. COVID-19 deaths so far are believed to stem from take-home infections and the lawsuits could cost businesses up to $21 billion if the number of Americans fatalities reaches 300,000, according to Praedicat, a firm that evaluates risks for insurers.
Most executives seek work-life balance after experiencing pandemic blues – survey
Many top company officials in France and Egypt were most likely to have recalibrated their lives after experiencing the pandemic blues, followed by those in the United Arab Emirates, the United States and Britain, according to a survey of about 2,000 high net-worth individuals by health insurer Bupa Global.
Poorer countries to get 120 million $5 coronavirus tests, WHO says
WHO Director General Tedros Adhanom Ghebreyesus said the manufacturers Abbott and SD Biosensor had agreed with the Bill & Melinda Gates Foundation to “make 120 million of these new, highly portable and easy-to-use rapid COVID-19 diagnostic tests available over a period of six months”.
“This will enable the expansion of testing, particularly in hard-to-reach areas that do not have laboratory facilities or enough trained health workers to carry out tests,” Tedros said.
Health ministry launches web portal for updates on COVID-19 vaccine development
“The data will serve as an invaluable tool for formulating appropriate patient management strategies, predicting disease severity, patient outcomes etc,” the ICMR said in a statement.
Union Health Minister Harsh Vardhan, said, “The portal provides useful and important information related to vaccine development, ongoing clinical trials and progress made in this area locally and globally at regular intervals. Today, in the times of coronavirus pandemic, vaccine development is watched very closely. Thus, it becomes important to showcase the status of vaccine development in the country.”
COVID tally crosses 60 lakh; 1,039 more deaths
The total coronavirus cases mounted to 60,74,702, while 50,16,520 people have recuperated from the virus, taking the recovery rate to 82.58 per cent. The case fatality rate declined to 1.57 per cent, it said.
Travellers from Dubai, UK mainly behind Covid importation into India: Study
The study has also found that infected cases from Tamil Nadu, Delhi and Andhra Pradesh played less role in spreading the disease outside their communities. Whereas infected people in Gujarat, Rajasthan, Maharashtra, Kerala, Jammu and Kashmir, and Karnataka played a significant role in the local transmission, and some of them caused interstate transfer too.
Antibodies from recovered cases, antivirals may be bridge to Covid vaccine
With no vaccines yet proven to prevent Covid-19, health authorities must continue to push for new treatments and measures to stop the coronavirus from spreading, said Robert “Chip” Schooley, a professor of medicine at the University of California, San Diego, who is studying more potent versions of an existing antiviral.